DexCom, Inc. (DXCM)

566.57
NASDAQ
Prev Close 568.10
Day Low/High 561.23 / 570.00
52 Wk Low/High 305.63 / 579.00
Exchange NASDAQ
Shares Outstanding 96.75B
Market Cap 54.96B
P/E Ratio 151.69
Div & Yield N.A. (N.A)
Jim Cramer: Report of Apple's Diabetes Test Isn't a Reason to Own the Stock

Jim Cramer: Report of Apple's Diabetes Test Isn't a Reason to Own the Stock

TheStreet's Action Alerts PLUS Portfolio Manager Jim Cramer said reports of Apple developing a diabetes testing product is not a reason to own the stock.

Trader's Daily Notebook: Worried About Volume? Just Let It Go

Trader's Daily Notebook: Worried About Volume? Just Let It Go

Old-line momentum favorites fare well.

Here's a New List of Stocks That Show Bullish or Bearish Reversal Patterns

Here's a New List of Stocks That Show Bullish or Bearish Reversal Patterns

These companies show signs of a change of direction.

DexCom: Look, but Don't Touch

DexCom: Look, but Don't Touch

The medical device company has been trading sideways for a long time and is likely to continue in the manner.

Dexcom downgraded at Morgan Stanley

Dexcom upgraded at Oppenheimer

Dexcom upgraded at BTIG

Cramer: Demand Lifts Defense, Aerospace, Cyber-Security, Regional Bank Stocks

Cramer: Demand Lifts Defense, Aerospace, Cyber-Security, Regional Bank Stocks

But several airline and retail stocks are proving highly volatile.

Sohn Picks Revisited: Mixed Results From David Einhorn & Jeffrey Smith

Sohn Picks Revisited: Mixed Results From David Einhorn & Jeffrey Smith

Results on conference picks are split as hedge fund industry contends with criticism.

2016 Sohn Investment Conference Live Blog: Session 2

2016 Sohn Investment Conference Live Blog: Session 2

David Einhorn, Jim Chanos presentations close out 2106's Sohn Investment Conference.

Mobile App Spurring Global Sales Says DexCom CEO

Mobile App Spurring Global Sales Says DexCom CEO

Shares of DexCom have bounced back 15% since hitting a 52-week low early last month, yet are still down 20% so far in 2016.

Bullish Volatility Visible in DexCom

Bullish Volatility Visible in DexCom

A combination of price and range compression often precedes volatility squeeze breakouts.

Dexcom upgraded at Leerink

Apple Stock Is Still Cheap

Apple Stock Is Still Cheap

Even at a record valuation, the shares seem poised to move higher.

Dexcom downgraded at Sterne Agee

The Bellwether We've Searched For

The Bellwether We've Searched For

You should be watching how DexCom is trading.

Dexcom upgraded at Sterne Agee

DexCom price target raised at Jefferies

From Type 1 Diabetic to an Advocate and Educator

From Type 1 Diabetic to an Advocate and Educator

Dexcom's Ashley Benedict shares her experience from diagnosis at age 7 to becoming an educator at the company that improved the quality of her life.

Dexcom Leading Diabetes Management

Dexcom Leading Diabetes Management

Dexcom CEO Terry Gregg reviews the tremendous growth the company saw in 2013 and how the company is improving the quality of life for diabetics. TheStreet's Jill Malandrino reports from the Nasdaq MarketSite in New York.

Weaving Another Basket

Weaving Another Basket

Building a new group of 15 names.